Rituximab and Azathioprine
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Medical College of Wisconsin
Overview
Rituximab and Azathioprine is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Rituximab and Azathioprine clinical trials
Explore related
Medical disclaimer. This page summarizes research about Rituximab and Azathioprine for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.